Aller au contenu principal
Profil bibliographique

Annalisa Bison Huckaby

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

27Publications signalées
179Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Bacterial Infections and VaccinesPneumonia and Respiratory InfectionsBacterial biofilms and quorum sensingSARS-CoV-2 and COVID-19 ResearchAntibiotic Resistance in Bacteria

Les publications récentes

Accès ouvert 2026 article OpenAlex

Development of a fluorescent reporter strain to facilitate studies of Borrelia burgdorferi pathogenesis

Annalisa Bison Huckaby, María de la Paz Gutierrez, Ching Wooen Sze, Barrett-Anne Briggs et autres

ABSTRACT Lyme disease is a tick-borne disease caused by spirochetes of the Borrelia burgdorferi sensu lato complex. Murine models of B. burgdorferi infection allows for the assessment of bacterial dissemination and presence through culture of infected tissue and dark-field microscopic examination after …

us (code pays fourni par la source)

0 citations Microbiology Spectrum
Accès ouvert 2026 article OpenAlex

Evaluation of EcoCRM, virus-like particles, and mRNA as vaccine platforms against Borrelia burgdorferi

Carleena M. Rocuskie-Marker, Annalisa Bison Huckaby, Olivia Conaway, Gage Michael Pyles et autres

Lyme disease (LD) is the most prevalent vector-borne disease in the United States, impacting ∼476,000 individuals annually with increasing incidence. Prevention relies on personal protective measures such as insecticides and tick checks, underscoring the need for new preventatives such as vaccines. In …

us (code pays fourni par la source)

0 citations Vaccine
Accès ouvert 2025 article OpenAlex

Co-administration of DTaP and mRNA COVID-19 vaccines results in altered immune profile and enhanced protection against aerosol challenge of B. pertussis in mice 3042

Nathaniel A. Rader, Dylan T. Boehm, Melissa Cooper, Casey C. Cunningham et autres

Abstract Description Children routinely receive COVID-19 mRNA vaccines alongside other regularly scheduled immunizations. It is known that mRNA vaccines are pro-inflammatory in nature which lead to protective immunity. Our goal was to investigate the effects of co-administering the COVID-19 mRNA vaccine alongside …

us (code pays fourni par la source)

0 citations The Journal of Immunology
Accès ouvert 2025 article OpenAlex

Sequencing-driven identification of immunotherapeutics for treatment of Lyme disease 4155

Annalisa Bison Huckaby, María de la Paz Gutierrez, Carleena Marie Rocuskie Marker, Spencer R. Dublin et autres

Abstract Description Lyme Disease (LD) is the number one tick-borne disease in the U.S., with an estimated incidence rate of at minimum 60,000 individuals each year. In the U.S., LD is caused by the gram-negative spirochete B. burgdorferi (Bb) and is transmitted …

us (code pays fourni par la source)

0 citations The Journal of Immunology
Accès ouvert 2025 article OpenAlex

Monoclonal therapeutic antibody synergizes with antibiotics to promote clearance of Pseudomonas aeruginosa 3062

Spencer R. Dublin, Samuel Ulicny, Annalisa Bison Huckaby, William T. Witt et autres

Abstract Description Pseudomonas aeruginosa is a ubiquitous, opportunistic Gram-negative pathogen. It is a prevalent hospital-acquired pathogen, and possesses multi-drug resistance (MDR), resulting in difficult to treat infections. The CDC has highlighted the need for novel strategies to combat these MDR strains of …

us (code pays fourni par la source)

0 citations The Journal of Immunology
Accès ouvert 2025 article OpenAlex

Evaluation of multiple platforms for the formulation of a multivalent vaccine against Borrelia burgdorferi 3064

Carleena Marie Rocuskie Marker, Annalisa Bison Huckaby, Gage Michael Pyles, María de la Paz Gutierrez et autres

Abstract Description Lyme disease (LD), caused by Borrelia burgdorferi, leads to an estimated 476,000 cases annually in the U.S. Furthermore, the presence of nonspecific LD symptoms frequently results in misdiagnosis and delayed treatment. Although LYMErix® showed initial promise with an rOspA vaccine …

us (code pays fourni par la source)

0 citations The Journal of Immunology
Accès ouvert 2025 article OpenAlex

GaSal-2: A Water-Soluble Antipseudomonal Agent Targeting the Extracellular Hemophore HasAp

Aziza Frank, Lucia Hwang, William T. Witt, Garrick Centola et autres

Multidrug-resistant Pseudomonas aeruginosa is a critical pathogen that demands new antibiotics. During P. aeruginosa infection, the extracellular hemophore hasAp and its outer membrane receptor hasR are the most dramatically upregulated genes. The P. aeruginosa Δ hasR strain exhibits significantly reduced growth and …

us, fr, ru (code pays fourni par la source)

0 citations ACS Infectious Diseases
Accès ouvert 2024 article OpenAlex

Novel broadly reactive monoclonal antibody protects against Pseudomonas aeruginosa infection

Margalida Mateu-Borrás, Spencer R. Dublin, Jason H. Kang, Hunter L. Monroe et autres

ABSTRACT The incidence of infections attributed to antimicrobial-resistant (AMR) pathogens has increased exponentially over the recent decades reaching 1.27 million deaths worldwide in 2019. Without intervention, these infections are predicted to cause up to 10 million deaths a year and incur costs …

us (code pays fourni par la source)

12 citations Infection and Immunity
Accès ouvert 2024 article OpenAlex

Virus-like particles displaying the mature C-terminal domain of filamentous hemagglutinin are immunogenic and protective against Bordetella pertussis respiratory infection in mice

Gage Michael Pyles, Annalisa Bison Huckaby, María de la Paz Gutierrez, William T. Witt et autres

ABSTRACT Bordetella pertussis, the bacterium responsible for whooping cough, remains a significant public health challenge despite the existing licensed pertussis vaccines. Current acellular pertussis vaccines, though having favorable reactogenicity and efficacy profiles, involve complex and costly production processes. In addition, acellular vaccines …

us (code pays fourni par la source)

4 citations Infection and Immunity
Accès ouvert 2024 article OpenAlex

Immunization with an mRNA DTP vaccine protects against pertussis in rats

Graham J. Bitzer, Nicholas A. Fitzgerald, Megan A. DeJong, Casey C. Cunningham et autres

ABSTRACT Bordetella pertussis is a Gram-negative bacterium that is the causative agent of the respiratory disease known as pertussis. Since the switch to the acellular vaccines of DTaP and Tap, pertussis cases in the US have risen and cyclically fallen. We have …

us (code pays fourni par la source)

5 citations Infection and Immunity
Accès ouvert 2024 article OpenAlex

Antibody-mediated immunological memory correlates with long-term Lyme veterinary vaccine protection in mice

María de la Paz Gutierrez, Annalisa Bison Huckaby, Evita Yang, Kelly L. Weaver et autres

Lyme disease, caused by the bacterium Borrelia burgdorferi, is the most common tick-borne illness in the United States. Despite the rise in Lyme disease incidence, there is no vaccine against B. burgdorferi approved for human use. Little is known about the immune …

us (code pays fourni par la source)

4 citations Vaccine
Accès ouvert 2024 article OpenAlex

BECC438b TLR4 agonist supports unique immune response profiles from nasal and muscular DTaP pertussis vaccines in murine challenge models

Megan A. DeJong, M. Allison Wolf, Graham J. Bitzer, Jesse M. Hall et autres

ABSTRACT The protection afforded by acellular pertussis vaccines wanes over time, and there is a need to develop improved vaccine formulations. Options to improve the vaccines involve the utilization of different adjuvants and administration via different routes. While intramuscular (IM) vaccination provides …

us (code pays fourni par la source)

5 citations Infection and Immunity

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.